Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro

International Immunopharmacology

Volumn 7, Issue 9, 2007, Pages 1211-1220

  Vucevic, Dragana ^a   Melliou, Eleni ^b   Vasilijic, Sasa ^a   Gasic, Sonja ^a   Ivanovski, Petar ^c   Chinou, Ioanna ^b   Colic, Miodrag ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF ATHENS   (Greece)

^c University Pediatric Clinic   (Serbia)

Author keywords

Cytokine production; Dendritic cells; Mixed leukocyte reaction; Royal jelly fatty acids; T cell proliferation

Indexed keywords

10 HYDROXY 2 DECANOIC ACID; 3,10 DIHYDROXYDECANOIC ACID; CD86 ANTIGEN; DECANOIC ACID DERIVATIVE; FATTY ACID DERIVATIVE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; KEYHOLE LIMPET HEMOCYANIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ROYAL JELLY; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG DOSE COMPARISON; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DECANOIC ACIDS; DENDRITIC CELLS; FATTY ACIDS; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; T-LYMPHOCYTES;

EID: 34447290482     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.05.005     Document Type: Article

References (41)

1. Karaali A., Meydanoglu F., and Eke D. Studies on composition freeze-drying and storage of Turkish royal jelly. J Apic Res 27 (1988) 182-185
2. Patel N.G., Haydak M., and Gochnauer T.A. Electrophoretic components of the proteins in honey bee larval food. Nature 186 (1960) 633-634
3. Bloodworth B.C., Harn C.S., Hock C.T., and Boon Y.O. Liquid chromatographic determination of trans-10-hydroxy-2-decenoic acid content of commercial products containing royal jelly. J AOAC Int 78 (1995) 1019-1023
4. Lercker G., Capella P., Conte L.S., Ruini F., and Giordani G. Components of royal jelly: I. Identification of the organic acids. Lipids 12 (1981) 912-919
5. Plettner E., Slessor K.N., and Winston M.L. Biosynthesis of mandibular acids in honeybees (Apis mellifera): de novo synthesis, route of fatty acid hydroxylation and caste selective b-oxidation. Insect Biochem Mol Biol 28 (1998) 31-42
6. Bincoletto C., Eberlin S., Figueiredo C.A., Luengo M.B., and Queiroz M.L. Effects produced by Royal Jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. Int Immunopharmacol 5 (2005) 679-688
7. Fontana R., Mendes M.A., de Souza B.M., Konno K., Cesar L.M., Malaspina O., et al. Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides 25 (2004) 919-928
8. Fujiwara S., Imai J., Fujiwara M., Yaeshima T., Kawashima T., and Kobayashi K. A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J Biol Chem 265 (1990) 11333-11337
9. Klaudiny J., Albert S., Bachanova K., Kopernicky J., and Simuth J. Two structurally different defensin genes, one of them encoding a novel defensin isoform, are expressed in honeybee Apis mellifera. Insect Biochem Mol Biol 35 (2005) 11-22
10. Shinoda M., Nakajin S., Oikawa T., Sato K., Kamogawa A., and Akiyama Y. Biochemical studies on vasodilative factor in royal jelly. Yakugaku Zasshi 98 (1978) 139-145
11. Vittek J. Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 51 (1995) 927-935
12. Okamoto I., Taniguchi Y., Kunikata T., Kohno K., Iwaki K., Ikeda M., et al. Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci 73 (2003) 2029-2045
13. Kohno K., Okamoto I., Sano O., Arai N., Iwaki K., Ikeda M., et al. Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 68 (2004) 138-145
14. Sver L., Orsolic N., Tadic Z., Njari B., Valpotic I., and Basic I. A royal jelly as a new potential immunomodulator in rats and mice. Comp Immunol Microbiol Infect Dis 19 (1996) 31-38
15. Liu L.S., Xiao X.N., and Zheng R.C. Therapeutic effect of royal jelly on radiation injury in mice and its possible mecnahism. Chung Hua Fang She I Hsueh Yu Fang Hu Tsa Chih 4 (1984) 25-26
16. Tamura T., Fujii A., and Kuboyama N. Antitumor effects of royal jelly (RJ). Nippon Yakurigaku Zasshi 89 (1987) 73-80
17. Majtan J., Kovacova E., Bilikova K., and Simuth J. The immunostimulatory effect of the recombinant apalbumin 1-major honeybee royal jelly protein-on TNFalpha release. Int Immunopharmacol 6 (2006) 269-278
18. Townsend G.F., Brown W.H., Felauer E.E., and Hazlett B. Studies on the in vitro antitumor activity of fatty acids. IV. The esters of acids closely related to 10-hydroxy-2-decenoic acids from royal jelly against transplantable mouse leukemia. Can J Biochem Physiol 39 (1961) 1765-1770
19. Melliou E., and Chinou I. Chemistry and bioactivity of royal jelly from Greece. J Agric Food Chem 53 (2005) 8987-8992
20. Steinman R.M., and Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311 (2006) 17-58
21. Rengarajan J., Szabo S.J., and Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21 (2000) 479-483
22. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
23. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 23 (2002) 509-512
24. Hemmi H., and Akira S. TLR signalling and the function of dendritic cells. Chem Immunol Allergy 86 (2005) 120-135
25. Fujii S., Liu K., Smith C., Bonito A.J., and Steinman R.M. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199 (2004) 1607-1618
26. Kajino K., Nakamura I., Bamba H., Sawai T., and Ogasawara K. Involvement of IL-10 in exhaustion of myeloid dendritic cells and rescue by CD40 stimulation. Immunology 120 (2007) 28-37
27. Koya-Miyata S., Okamoto I., Ushio S., Iwaki K., Ikeda M., and Kurimoto M. Identification of a collagen production-promoting factor from an extract of royal jelly and its possible mechanism. Biosci Biotechnol Biochem 68 (2004) 767-773
28. Wahl S.M., Swisher J., McCartney-Francis N., and Chen W. TGF-{beta}: the perpetrator of immune suppression by regulatory T cells and suicidal T cells. J Leukoc Biol 76 (2004) 15-24
29. Pollet S., Bottex-Gauthier C., Li M., Potier P., Favier A., and Vidal D. Insight into some of the signaling pathways triggered by a lipid immunomodulator. Immunopharmacol Immunotoxicol 24 (2002) 527-546
30. Li Q., and Verma I.M. NF-kappaB regulation in the immune system. Nat Rev Immunol 2 (2002) 725-734
31. Calder P.C. N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled water or another fishy tale?. Nutr. Res. 21 (2001) 309-341
32. Endres S., Meydani S.N., Ghorbani R., Schindler R., and Dinarello C.A. Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. Leukoc Biol 54 (1993) 599-603
33. Kelley D.S. Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 17 (2001) 669-673
34. Khan N.A., Yessoufou A., Kim M., and Hichami A. N-3 fatty acids modulate Th1 and Th2 dichotomy in diabetic pregnancy and macrosomia. J Autoimmun 26 (2006) 268-277
35. Cavaglieri C.R., Nishiyama A., Fernandes L.C., Curi R., Miles E.A., and Calder P.C. Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes. Life Sci 73 (2003) 1683-1690
36. Salem M.L. Systemic treatment with n-6 polyunsaturated fatty acids attenuates EL4 thymoma growth and metastasis through enhancing specific and non-specific anti-tumor cytolytic activities and production of TH1 cytokines. Int Immunopharmacol 5 (2005) 947-960
37. Kitanaka N., Owada Y., Okuyama R., Sakagami H., Nourani M.R., Aiba S., et al. Epidermal-type fatty acid binding protein as a negative regulator of IL-12 production in dendritic cells. Biochem Biophys Res Commun 345 (2006) 459-466
38. Zeyda M., Saemann M.D., Stuhlmeier K.M., Mascher D.G., Nowotny P.N., Zlabinger G.J., et al. Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. J Biol Chem 280 (2005) 14293-14301
39. Arterburn L.M., Hall E.B., and Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 83 (2006) 1467S-1476S
40. Bryhn M., Hansteen H., Schanche T., and Aakre S.E. The bioavailability and pharmacodynamics of different concentrations of omega-3 acid ethyl esters. Prostaglandins Leukot Essent Fatty Acids 75 (2006) 19-24
41. Young G.S., Conquer J.A., and Thomas R. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder. Reprod Nutr Dev 45 (2005) 549-558